<DOC>
	<DOCNO>NCT00768105</DOCNO>
	<brief_summary>The purpose study assess safety tolerability AZD1656 multiple repeat oral dos patient type 2 diabetes top insulin .</brief_summary>
	<brief_title>To Evaluate Safety Tolerability After Multiple Oral Doses AZD1656 Type 2 Diabetes Patients Top Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Female non childbearing potential Diagnosed Diabetes Mellitus patient treat insulin alone insulin combination antidiabetic drug . Stable blood sugar control indicate change treatment within 3 month prior study start . HbA1c equal 11 % screening ( HbA1c value accord international DCCT standard ) Clinically significant illness clinically relevant trauma , judge investigator , within two week first administration IP History ischemic heart disease , stroke , transitorisk ischemic attack symptomatic peripheral vascular disease Clinically significant abnormality clinical chemistry , hematology , urinalysis result .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Type 2 diabetes</keyword>
</DOC>